R&D

Glaxo faces another cardio R&D failure for a lead candidate
BioPharma Dive
Wed, 10/28/15 - 02:55 pm
GSK
R&D
losmapimod
Does M&A Still Have a Future in Big Pharma?
Forbes
Tue, 10/27/15 - 03:41 pm
M&A
Big Pharma
Valeant Pharmaceuticals
R&D
Here's how Raleigh's BioDelivery plans to spend $50 million
Bizjournals.com
Mon, 10/26/15 - 09:46 pm
BioDelivery Sciences
R&D
Belbuca
Endo International
Valeant To Double Its R&D - To Do What?
Forbes
Mon, 10/26/15 - 08:33 am
Valeant Pharmaceuticals
R&D
Analyzing Gilead Sciences’ Research and Development in 3Q15
Yahoo/Market Realist
Sat, 10/24/15 - 03:40 pm
Gilead Sciences
R&D
Glaxo, Pfizer, U.K. Form $100 Million Alzheimer's Research Fund
Bloomberg
Tue, 10/20/15 - 10:03 pm
GSK
Pfizer
UK
Alzheimer's disease
R&D
Valeant changes its spots with promises to limit price hikes, spend more on R&D
Fierce Pharma
Tue, 10/20/15 - 06:10 pm
Valeant Pharmaceuticals
drug pricing
R&D
Genentech co-signs Nimbus' computer-aided R&D with an oncology pact
Fierce Biotech
Tue, 10/20/15 - 05:59 pm
Genentech
R&D
Nimbus
IRAK4
In The R&D Drug Lottery, Biopharma Is Putting Most Chips On The Big Prizes
Forbes
Thu, 10/15/15 - 09:40 am
R&D
Moderna's top scientist steps down amid a billion-dollar R&D push
Fierce Biotech
Tue, 10/13/15 - 10:20 pm
Moderna Therapeutics
R&D
Protalix flips its Gaucher drug to Pfizer for $46M in R&D cash
Fierce Biotech
Tue, 10/13/15 - 12:16 pm
Protalix BioTherapeutics
Pfizer
R&D
Gaucher disease
Elelyso
Experts push for trials to evaluate Roche, GSK flu drugs' pandemic potential
Fierce Pharma
Fri, 10/9/15 - 10:07 am
Roche
GSK
influenza
R&D
Amgen Turning the Tables on 'Generic' Competition
Motley Fool
Wed, 10/7/15 - 09:59 am
Amgen
biosimilars
generics
patents
R&D
Xenoport to seek partner to develop drug; CEO steps down
Yahoo/Reuters
Fri, 10/2/15 - 09:15 am
XenoPort
R&D
Pharma CEOs
XP23829
Sofinnova leads a $30.6M round for Asceneuron's Alzheimer's R&D
Fierce Biotech
Wed, 09/30/15 - 09:32 am
Asceneuron
Merck Serono
R&D
Alzheimer's disease
Sorrento launches another joint venture with a $170M cancer deal
Fierce Biotech
Mon, 09/28/15 - 11:54 am
Sorrento Therapeutics
R&D
cancer
antibodies
Why Clinton Drug Cost Cap, R&D Mandate Hurt Valeant
Investors.com
Sun, 09/27/15 - 08:34 pm
Hillary Clinton
drug pricing
R&D
Valeant Pharmaceuticals
Troubled GlaxoSmithKline to shutter R&D facility in France
Fierce Biotech
Fri, 09/25/15 - 10:23 am
GSK
France
R&D
Embracing biotech, Nestlé recruits AC Immune for an Alzheimer's project
Fierce Biotech
Fri, 09/25/15 - 10:07 am
Alzheimer's disease
Nestle
AC Immune
R&D
Boehringer finalizes team for crowdsourced COPD R&D initiative
Fierce Biotech
Thu, 09/24/15 - 07:14 pm
Boehringer Ingelheim
COPD
R&D
crowdsourcing
BioMed X
epigenetics

Pages